Literature DB >> 10077601

Regulation of endogenous E2F1 stability by the retinoblastoma family proteins.

F Martelli1, D M Livingston.   

Abstract

Certain E2F transcription factor species play a pivotal role in regulating cell-cycle progression. The activity of E2F1, a protein with neoplastic transforming activity when unregulated, is tightly controlled at the transcriptional level during G0 exit. In addition, during this interval, the stability of endogenous E2F1 protein increased markedly. E2F1 stability also was dynamically regulated during myogenic differentiation and in response to gamma irradiation. One or more retinoblastoma family proteins likely participate in the stability process, because simian virus 40 T antigen disrupted E2F1 stability regulation during G1 exit in a manner dependent on its ability to bind to pocket proteins. Thus, endogenous E2F1 function is regulated by both transcriptional and posttranscriptional control mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077601      PMCID: PMC15859          DOI: 10.1073/pnas.96.6.2858

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  E2F-1 functions in mice to promote apoptosis and suppress proliferation.

Authors:  S J Field; F Y Tsai; F Kuo; A M Zubiaga; W G Kaelin; D M Livingston; S H Orkin; M E Greenberg
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

2.  Tumor induction and tissue atrophy in mice lacking E2F-1.

Authors:  L Yamasaki; T Jacks; R Bronson; E Goillot; E Harlow; N J Dyson
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

3.  Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts.

Authors:  Z M Wang; H Yang; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 4.  Ubiquitin, proteasomes, and the regulation of intracellular protein degradation.

Authors:  M Hochstrasser
Journal:  Curr Opin Cell Biol       Date:  1995-04       Impact factor: 8.382

5.  Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint.

Authors:  W Krek; G Xu; D M Livingston
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

6.  A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.

Authors:  W R Sellers; J W Rodgers; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  Multiple members of the E2F transcription factor family are the products of oncogenes.

Authors:  G Xu; D M Livingston; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Mechanism of active transcriptional repression by the retinoblastoma protein.

Authors:  S J Weintraub; K N Chow; R X Luo; S H Zhang; S He; D C Dean
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

9.  Degradation of CFTR by the ubiquitin-proteasome pathway.

Authors:  C L Ward; S Omura; R R Kopito
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

10.  Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation.

Authors:  J Zalvide; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

View more
  10 in total

1.  p19ARF targets certain E2F species for degradation.

Authors:  F Martelli; T Hamilton; D P Silver; N E Sharpless; N Bardeesy; M Rokas; R A DePinho; D M Livingston; S R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis.

Authors:  Bing Wang; Kang Liu; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

3.  Rbf1 degron dysfunction enhances cellular DNA replication.

Authors:  Nitin Raj; Liang Zhang; Yiliang Wei; David N Arnosti; R William Henry
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

4.  Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.

Authors:  Xinglong Wang; Bo Su; Hisashi Fujioka; Xiongwei Zhu
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

5.  Regulation of E2F1 activity by acetylation.

Authors:  M A Martínez-Balbás; U M Bauer; S J Nielsen; A Brehm; T Kouzarides
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

6.  E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation.

Authors:  Jone Mitxelena; Aintzane Apraiz; Jon Vallejo-Rodríguez; Marcos Malumbres; Ana M Zubiaga
Journal:  Nucleic Acids Res       Date:  2016-03-09       Impact factor: 16.971

7.  Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors.

Authors:  Pooja Sharma; Sarah Alsharif; Karina Bursch; Swetha Parvathaneni; Dimitrios G Anastasakis; Joeffrey Chahine; Arwa Fallatah; Kevin Nicolas; Sudha Sharma; Markus Hafner; Bhaskar Kallakury; Byung Min Chung
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

8.  The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted.

Authors:  Enbo Liu; Alan Yueh-Luen Lee; Takuya Chiba; Erin Olson; Peiqing Sun; Xiaohua Wu
Journal:  J Cell Biol       Date:  2007-11-19       Impact factor: 10.539

9.  E2F2 and CREB cooperatively regulate transcriptional activity of cell cycle genes.

Authors:  Usua Laresgoiti; Aintzane Apraiz; Miguel Olea; Jone Mitxelena; Nerea Osinalde; José A Rodriguez; Asier Fullaondo; Ana M Zubiaga
Journal:  Nucleic Acids Res       Date:  2013-09-12       Impact factor: 16.971

10.  GTSE1: a novel TEAD4-E2F1 target gene involved in cell protrusions formation in triple-negative breast cancer cell models.

Authors:  Debora Stelitano; Leticia Yamila Peche; Emiliano Dalla; Martin Monte; Silvano Piazza; Claudio Schneider
Journal:  Oncotarget       Date:  2017-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.